VSFCX | VSIIX | VSFCX / VSIIX | |
Total Expense Ratio | 1.96 | 0.06 | 3,267% |
Annual Report Gross Expense Ratio | 2.23 | 0.06 | 3,717% |
Fund Existence | 29 years | 26 years | - |
Gain YTD | -5.649 | -4.253 | 133% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1500 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 152M | 54B | 0% |
Annual Yield % from dividends | 0.34 | 2.24 | 15% |
Returns for 1 year | -8.06 | 3.02 | -267% |
Returns for 3 years | -14.37 | 12.14 | -118% |
Returns for 5 years | 22.09 | 64.96 | 34% |
Returns for 10 years | -16.23 | 82.85 | -20% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBBQ | 21.25 | 0.34 | +1.63% |
Invesco Nasdaq Biotechnology ETF | |||
RSP | 178.69 | 1.53 | +0.86% |
Invesco S&P 500® Equal Weight ETF | |||
RYLD | 14.75 | 0.12 | +0.82% |
Global X Russell 2000 Covered Call ETF | |||
CHGX | 25.37 | 0.18 | +0.71% |
Stance Sustainable Beta ETF | |||
RWX | 26.85 | 0.02 | +0.07% |
SPDR® Dow Jones® International RelEstETF |